Gregor B. E. Jemec

42.7k citations
817 papers · 33.3k · 19 hit papers · h-index 90

Impact in

  • Dermatology top 0.01%
    • Hidradenitis Suppurativa and Treatments
    • Dermatology and Skin Diseases
    • Contact Dermatitis and Allergies
    • Acne and Rosacea Treatments and Effects
  • Immunology top 1%
    • Psoriasis: Treatment and Pathogenesis

Papers in

    • Hidradenitis Suppurativa and Treatments 330
    • Dermatology and Skin Diseases 88
    • Contact Dermatitis and Allergies 38
    • Acne and Rosacea Treatments and Effects 23
    • Nonmelanoma Skin Cancer Studies 50
    • Nail Diseases and Treatments 31

Gregor B. E. Jemec

784 papers receiving 31.8k citations

Gregor B. E. Jemec's Hit Papers

Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials 2024 · 110 citations
1100+4+8Years since publication250500750

Peers

Gregor B. E. Jemec
Comparison fields: 5 of 186
  • Dermatology 21.5k
  • Immunology 1.7k
  • Rehabilitation 480
  • Epidemiology 2.4k
  • Pharmaceutical Science 460
Replace Peter Josef Altmeyer with:
Peter Josef Altmeyer Germany
Wolfram Sterry Germany
Amy S. Paller United States
Ronald Marks United Kingdom
Uwe Wollina Germany
Torello Lotti Italy
Alain Taı̈eb France
Tilo Biedermann Germany
Thomas Werfel Germany
Lajos Vince Kemény Hungary
Gregor B. E. Jemec relative to Peter Josef Altmeyer Germany Peter Josef Altmeyer's profile →
Citations per field
00.5×5×10×13.0×
Peter Josef Altmeyer · 1×
Citations per year

Countries citing papers authored by Gregor B. E. Jemec

Since Specialization
Citations

This map shows the geographic impact of Gregor B. E. Jemec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregor B. E. Jemec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregor B. E. Jemec more than expected).

Fields of papers citing papers by Gregor B. E. Jemec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregor B. E. Jemec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregor B. E. Jemec. The network helps show where Gregor B. E. Jemec may publish in the future.

Co-authors

The 25 scholars most cited alongside Gregor B. E. Jemec, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gregor B. E. Jemec Line = papers co-authored together Gregor B. E. Jemec links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 817 papers — load more, or switch the sort, to bring in the rest.

#Work
1
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
Hit paper breakdown →
2015855
2
The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries
Hit paper breakdown →
2014726
3
Hidradenitis Suppurativa
Hit paper breakdown →
2012679
4
Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
Hit paper breakdown →
2016628
5
Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity
Hit paper breakdown →
2009460
6
Hidradenitis suppurativa
Hit paper breakdown →
2020436
7
The prevalence of hidradenitis suppurativa and its potential precursor lesions
Hit paper breakdown →
1996418
8
Development and validation of the International Hidradenitis Suppurativa Severity Score System ( IHS 4), a novel dynamic scoring system to assess HS severity
Hit paper breakdown →
2017381
9
Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa
Hit paper breakdown →
2012361
10
Hidradenitis Suppurativa
Hit paper breakdown →
2017359
11
Diagnostic delay in hidradenitis suppurativa is a global problem
Hit paper breakdown →
2015320
12
Hidradenitis Suppurativa/Acne Inversa: Criteria for Diagnosis, Severity Assessment, Classification and Disease Evaluation
Hit paper breakdown →
2015305
13 2008301
14 2010297
15 2001293
16
The sequences of 150,119 genomes in the UK Biobank
Hit paper breakdown →
2022288
17
Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life
Hit paper breakdown →
2020282
18 2006279
19 2013268
20 1998267

About Gregor B. E. Jemec

Gregor B. E. Jemec is a scholar working on Dermatology, Epidemiology, Biomedical Engineering, Immunology and Rehabilitation, having authored 817 papers that have together received 33.3k indexed citations. Recurring topics across this work include Hidradenitis Suppurativa and Treatments (330 papers), Dermatology and Skin Diseases (88 papers), Optical Coherence Tomography Applications (54 papers), Nonmelanoma Skin Cancer Studies (50 papers), Contact Dermatitis and Allergies (38 papers), Psoriasis: Treatment and Pathogenesis (31 papers), Nail Diseases and Treatments (31 papers) and Acne and Rosacea Treatments and Effects (23 papers). The work is most often cited by research in Dermatology (21.5k citations), Immunology (1.7k citations), Rehabilitation (480 citations), Epidemiology (2.4k citations) and Pharmaceutical Science (460 citations). Gregor B. E. Jemec has collaborated with scholars based in Denmark, United States and Germany. Frequent co-authors include Errol Prospero Prens, Ditte Marie Lindhardt Saunte, Solveig Esmann, Mette Mogensen, Christos C. Zouboulis, Lennart Emtestam, Iben Marie Miller, Ximena Wortsman, Alexa B. Kimball and Hessel H. van der Zee. Their work appears in journals such as Journal of the European Academy of Dermatology and Venereology, British Journal of Dermatology, Dermatology, Acta Dermato Venereologica and Journal of the American Academy of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact